Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Bal Pharma Limited, is a listed public company incorporated on 19 May, 1987. It is classified as a public limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 20.00 cr and the total paid-up capital is INR 15.92 cr.
Bal Pharma Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 12.2% over the previous year. At the same time, it's book networth has increased by 9.98%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
8.11%
12.2%
-28.58%
9.98%
27.78%
20.06%
3.32
0.31
-0.98
-3.44
0.8
0.18
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(16)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 8
Total Amount : 96.3 cr
Canara Bank
No. of Loans: 2
Total Amount : 58.8 cr
SOUTH INDIAN BANK LTD
No. of Loans: 1
Total Amount : 8.3 cr
Small Industries Development Bank of India
No. of Loans: 1
Total Amount : 4.3 cr
STCI FINANCE LIMITED
No. of Loans: 1
Total Amount : 1.1 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Managing Director | Shailesh Siroya
Shareholder
|
00048109 | 20 years |
| Director | Jatish Sheth | 00581963 | 4 years |
| Director | H S Venkatesh | 01776040 | 5 years |
| Director | Nicola Neeladri | 01997936 | 5 years |
| Whole-time Director | Virupakshaya Himesh
Shareholder
|
08554422 | 5 years |
| Whole-time Director | Chittanand Damodar Kotian
Shareholder
|
09613054 | 3 years |
| CFO | Daddanala Venkat Bharath Bhushan | <HIDDEN> | 2 years |
| Kmp | Abdul . Basith | <HIDDEN> | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| NOVOSYNTH RESEARCH LABS PRIVATE LIMITED |
Strike Off
|
3.5 L | 1 | Karnataka |
| SANJAY GEMS PVT LTD |
Strike Off
|
1.1 L | 1 | Maharashtra |
| LEGEND SIROYA INFRASTRUCTURE PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
| KAUNSHYA INVESTMENTS PRIVATE LIMITED |
Active
|
81.0 L | 1 | Karnataka |
| SIROYA PROPERTIES & HOLDINGS PRIVATE LIMITED |
Under Process of Striking Off
|
1.0 L | 1 | Karnataka |
| BAL RESEARCH FOUNDATION |
Active
|
10.0 L | 1 | Karnataka |
| LIFEZEN HEALTHCARE PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Karnataka |
| SIROYA BUILDERS & REAL ESTATES PRIVATE LIMITED |
Under Process of Striking Off
|
1.0 L | 1 | Karnataka |
| BASAV CHEM LIMITED |
Amalgamated
|
10.0 L | 1 | Karnataka |
| AURUM RESEARCH & ANALYTICAL SOLUTIONS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Karnataka |
| GROW INDIA FINANCIAL ADVISORS LLP |
Strike Off
|
1.0 L | 1 | Karnataka |
| BALANCE CLINICS LLP |
Active
|
10.0 L | 1 | Karnataka |
| GOLDEN DRUGS PRIVATE LIMITED |
Active
|
3.6 Cr | 1 | Karnataka |
| MEGANZA PHARMA LLP |
Active
|
50,000.0 | 1 | Karnataka |
| SRUSHTI PHARMACEUTICALS PRIVATE LIMITED |
Active
|
6.8 L | 1 | Karnataka |
| MRO-TEK REALTY LIMITED |
Active
|
9.3 Cr | 2 | Karnataka |
| WILDCRAFT INDIA LIMITED |
Active
|
55.7 Cr | 1 | Karnataka |
| ISG NOVASOFT TECHNOLOGIES LIMITED |
Active
|
36.2 Cr | 1 | Karnataka |
| RED SUN DIAMONDS IMPEX PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Karnataka |
| RED SUN INFORMATION TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Karnataka |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| LIFEZEN HEALTHCARE PRIVATE LIMITED | Karnataka | 2014 | ₹ 2.0 Cr |
| BAL RESEARCH FOUNDATION | Karnataka | 2014 | ₹ 10.0 L |
| BALANCE CLINICS LLP | India | - | - |
| GOLDEN DRUGS PRIVATE LIMITED | Karnataka | 2012 | ₹ 3.6 Cr |
| Balance Clinics LLP | India | - | - |
The incorporation date of BAL PHARMA LIMITED is 19 May, 1987
The authorized share capital of BAL PHARMA LIMITED is INR ₹ 20.0 Cr.
The paid-up capital of BAL PHARMA LIMITED is INR ₹ 15.9 Cr.
The registered address of BAL PHARMA LIMITED is 21-22, BOMMASANDRA INDUSTRIAL AREA Bommasandra Industrial Es tate Bangalore South Bangalore Karnataka - 560099
The CIN number of BAL PHARMA LIMITED is L85110KA1987PLC008368.
Expand
Delete
Collapse
See
details
